Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    19 May 2025

    Arecor establishes partnership with Skye Bioscience to develop enhanced formulation of obesity candidate Nimacimab

    Arecor Therapeutics plc, the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces a formulation development collaboration with Skye Bioscience, a clinical-stage biotechnology company focused on obesity and other metabolic health disorders. ...

    22 May 2025

    £1 billion BioNTech investment sets way for jobs, growth, breakthroughs

    Covid-19 vaccine pioneers BioNTech commit to up to £1 billion, 10-year investment in the UK. ...

    21 May 2025


    Maxion Therapeutics doubles R&D space at Unity Campus after £58 million Series A fundraise

    Cambridge - Leading regional property investor and developer Howard Group, is delighted to announce that pioneering biotechnology company Maxion Therapeutics has more than doubled its footprint at Unity Campus. ...

    23 May 2025

    Leo James, Greg Jefferis and Marta Zlatic elected to Royal Society

    Leo James, Greg Jefferis and Marta Zlatic, all Group Leaders at the LMB, have been elected Fellows of the Royal Society. ...

    23 May 2025

    Enhanced breast cancer screening could detect an extra 3,500 cancers per year

    Researchers in Cambridge are calling for additional scans to be added to breast screening for women with very dense breasts. This follows a large-scale trial, which shows that extra scans could treble cancer detection for these women potentially saving up to 700 lives a year in the UK. ...

    29 May 2025

    Childhood kidney cancer has millions of genetic changes, opening door to possible treatments

    Researchers have uncovered that some childhood cancers have a substantially higher number of DNA changes than previously thought, changing the way we view children’s tumours and possibly opening up new or repurposed treatment options. ...

    29 May 2025

    Dinosaurs could hold key to cancer discoveries

    New study highlights the importance of preserving fossilised soft tissues.

    30 May 2025

    Ireland adopts Cambridge-developed method to monitor early prostate cancer

    Development of the first evidence-based tool that helps clinicians actively monitor early prostate cancer in newly diagnosed patients has won important recognition in Ireland following research in Cambridge. ...

    5 June 2025

    Baby’s microbiome may protect against childhood viral infection

    A baby's makeup of gut bacteria — their microbiome — which starts to form as soon as they are born, could help protect against viral infections later in childhood, a new study suggests. ...

    6 June 2025

    Brain injury survivors help shape new medical technologies

    Researchers based at Cambridge University Hospitals NHS Foundation Trust (CUH) have developed a programme to ensure that the development of medical technology is in line with the unmet needs of brain injury survivors. ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 66
    • Page 67
    • Current page 68
    • Page 69
    • Page 70
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS